Table 3 Changes in inflammatory biomarkers during the experiments
Inflammatory biomarkers | HD start | End of study | pa | pb | ||
|---|---|---|---|---|---|---|
(0Â min) | (360Â min) | |||||
P-Albumin (g/L) | Overall: | 38.8 ± 2.1 | Overall: | 40.4 ± 2.5 | 0.12 | < 0.001 |
Mean ± SD | NT: | 39.5 ± 1.4 | NT: | 41.3 ± 2.3 |  |  |
|  | G: | 38.1 ± 1.9 | G: | 40.4 ± 2.7 |  |  |
|  | GI: | 38.6 ± 2.8 | GI: | 39.6 ± 2.4 |  |  |
P-Fibrinogen (μmol/L) | Overall: | 11.7 ± 1.7 | Overall: | 12.8 ± 1.8 | 0.12 | < 0.001 |
Mean ± SD | NT: | 11.9 ± 1.9 | NT: | 13.0 ± 2.0 | ||
|  | G: | 11.6 ± 1.6 | G: | 12.6 ± 1.6 | ||
GI: | 11.7 ± 1.9 | GI: | 12.8 ± 2.0 | |||
S-hsCRP (mg/L) | Overall: | 4.52 [0.40-10.68] | Overall: | 4.67 [0.44-11.25] | 0.61 | 0.55 |
Median [range] | NT: | 4.75 [0.58-10.08] | NT: | 6.06 [0.55-11.25] | ||
| Â | G: | 3.21 [0.50-8.20] | G: | 3.35 [0.57-7.96] | ||
| Â | GI: | 6.48 [0.40-10.68] | GI: | 6.40 [0.44-10.23] | ||
P-IL-1β (ng/L) | Overall: | 0.042 [0.010-0.185] | Overall: | 0.039 [0.010-0.095] | 0.68 | 0.002 |
Median [range] | NT: | 0.042 [0.011-0.185] | NT: | 0.031 [0.011-0.049] | ||
| Â | G: | 0.041 [0.010-0.157] | G: | 0.039 [0.010-0.095] | ||
| Â | GI: | 0.043 [0.010-0.166] | GI: | 0.039 [0.029-0.079] | ||
P-IL-6 (ng/L) | Overall: | 0.19 [0.04-2.33] | Overall: | 0.18 [0.02-0.89] | 0.96 | 0.25 |
Median [range] | NT: | 0.14 [0.08-1.84] | NT: | 0.19 [0.04-0.89] | ||
| Â | G: | 0.21 [0.04-0.97] | G: | 0.17 [0.05-0.34] | ||
| Â | GI: | 0.20 [0.06-2.33] | GI: | 0.30 [0.02-0.45] | ||
P-TNF-α (ng/L) | Overall: | 0.42 [0.02-9.36] | Overall: | 0.29 [0.02-1.82] | 0.76 | 0.09 |
Median [range] | NT: | 0.27 [0.10-8.53] | NT: | 0.27 [0.02-1.82] | ||
| Â | G: | 0.51 [0.02-2.89] | G: | 0.26 [0.03-1.75] | ||
| Â | GI: | 0.36 [0.25-9.36] | GI: | 0.46 [0.25-1.33] | ||